Patents by Inventor Elias Reichel
Elias Reichel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230158049Abstract: Disclosed are compositions and methods that can be used for the prevention, mitigation, and/or prophylactic treatment of a viral infection, such but not limited to a coronavirus infection, such as but not limited to a COVID-19 infection. In some embodiments, a chemically modified tetracycline (CMT) derivative for the prevention, mitigation and/or prophylactic treatment of a viral infection is provided. In some embodiments, the CMT derivative lacks anti-microbial activity; comprises a phenol ring; and/or comprises a chemical structure sufficient to chelate and/or bind a divalent cation. In some embodiments, the divalent cation comprises Zn2+. In some embodiments, the viral infection is a coronavirus infection. In some embodiments, the viral infection is a COVID-19 infection.Type: ApplicationFiled: April 6, 2021Publication date: May 25, 2023Inventors: Paul Andrew Yates, Elias Reichel, Ashton Leone
-
Publication number: 20220184102Abstract: Provided are chemically modified tetracycline (CMT) derivatives for the treatment of non-exudative macular degeneration. The CMT derivatives lack antimicrobial activity, include a phenol ring, and a chemical structure sufficient to chelate Zn2+. Methods of inhibiting and/or minimizing inflammation in a subject, including administering to the subject a dose of a CMT derivative, are also provided. Methods of treating non-exudative age-related macular degeneration (AMD) are provided.Type: ApplicationFiled: March 27, 2020Publication date: June 16, 2022Inventors: Paul Andrew Yates, Elias Reichel, Ashton Leone
-
Patent number: 10045955Abstract: The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vulvovaginal pain, such as dyspareunia by topically administering said composition.Type: GrantFiled: January 22, 2018Date of Patent: August 14, 2018Assignee: ELLE PHARMACEUTICAL, LLCInventors: Elias Reichel, Lauren Oshry
-
Publication number: 20180153832Abstract: The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vulvovaginal pain, such as dyspareunia by topically administering said composition.Type: ApplicationFiled: January 22, 2018Publication date: June 7, 2018Inventors: Elias Reichel, Lauren Oshry
-
Patent number: 9907749Abstract: The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vulvovaginal pain, such as dyspareunia by topically administering said composition.Type: GrantFiled: February 28, 2017Date of Patent: March 6, 2018Assignee: ELLE PHARMACEUTICAL, LLCInventors: Lauren Oshry, Elias Reichel
-
Patent number: 9814675Abstract: The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vaginal pain, such as dyspareunia by topically administering said composition.Type: GrantFiled: January 20, 2017Date of Patent: November 14, 2017Assignee: ELLE PHARMACEUTICAL, LLCInventors: Lauren Oshry, Elias Reichel
-
Publication number: 20170239181Abstract: The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vulvovaginal pain, such as dyspareunia by topically administering said composition.Type: ApplicationFiled: February 28, 2017Publication date: August 24, 2017Inventors: Lauren Oshry, Elias Reichel
-
Publication number: 20170239180Abstract: The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vaginal pain, such as dyspareunia by topically administering said composition.Type: ApplicationFiled: January 20, 2017Publication date: August 24, 2017Inventors: Lauren Oshry, Elias Reichel
-
Patent number: 8759401Abstract: Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.Type: GrantFiled: August 7, 2013Date of Patent: June 24, 2014Assignee: Akorn, Inc.Inventors: Abu Alam, Elias Reichel, Brandon Busbee
-
Publication number: 20130324612Abstract: Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.Type: ApplicationFiled: August 7, 2013Publication date: December 5, 2013Applicant: Akorn, Inc.Inventors: Abu Alam, Elias Reichel, Brandon Busbee
-
Publication number: 20120034307Abstract: Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.Type: ApplicationFiled: October 20, 2011Publication date: February 9, 2012Applicant: AKORN, INC.Inventors: Abu Alam, Elias Reichel, Brandon Busbee
-
Publication number: 20090123527Abstract: Disclosed is a method of inducing topical anesthesia in a tissue or organ of an animal comprising providing an aqueous gel formulation comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed are a transdermal patch comprising the aqueous gel formulation suitable for applying on the skin of a patient and a method of controlling pain therewith.Type: ApplicationFiled: January 15, 2009Publication date: May 14, 2009Applicant: Akorn, Inc.Inventors: ABU ALAM, Elias Reichel, Brandon Busbee
-
Publication number: 20080021068Abstract: Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.Type: ApplicationFiled: July 24, 2006Publication date: January 24, 2008Applicant: Akorn, Inc.Inventors: Abu Alam, Elias Reichel, Brandon Busbee
-
Publication number: 20080020044Abstract: Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.Type: ApplicationFiled: May 7, 2007Publication date: January 24, 2008Applicant: Akorn, Inc.Inventors: Abu Alam, Elias Reichel, Brandon Busbee